肥胖患者腹腔镜肝切除术后并发症与教科书结局的相关因素:法国全国性研究
该法国多中心研究纳入1996至2018年间3154例腹腔镜肝切除患者,其中肥胖(BMI≥30 kg/m²)616例(19.5%)。肥胖组总体并发症和住院时间显著增加,但严重90天并发症和死亡率与对照组相似;肥胖与较低的教科书结局率独立相关(OR=0.8,95%CI 0.7-1.0;P=0.03)。
要点
- 肥胖患者腹腔镜肝切除的死亡率和严重90天并发症与不肥胖者相似。
- 肥胖与较低的教科书结局率独立相关(OR=0.8,95%CI 0.7-1.0;P=0.03)。
- 肥胖患者总体并发症和住院时间显著增加,但严重并发症无差异。
核心结论
- 肥胖患者行腹腔镜肝切除安全有效,死亡率和严重并发症可接受。
- 肥胖对严重并发症无影响,但与较低的教科书结局率相关。
研究设计与样本
- 法国多中心研究,纳入1996至2018年间接受腹腔镜肝切除的患者。
- 共纳入3154例患者,肥胖定义为BMI≥30 kg/m²,肥胖616例(19.5%)。
主要发现
- 肥胖组与非肥胖组死亡率相似(0.8% vs 1.1%;P=0.66)。
- 肥胖组总体并发症显著增加(39.4% vs 34.7%;P=0.03),住院时间显著延长(9.5 vs 8.6天;P=0.02)。
- 两组严重90天并发症(Clavien-Dindo≥III级)相似(均为8%;P=0.90)。
- 肥胖组教科书结局率显著低于非肥胖组(58.3% vs 63.7%;P=0.01)。
- 多因素分析中,肥胖不是严重90天并发症的危险因素,但与较低的教科书结局率相关(OR=0.8,95%CI 0.7-1.0;P=0.03)。
临床怎么用
- 肥胖患者行腹腔镜肝切除前应充分评估,预期总体并发症和住院时间可能增加。
- 肥胖患者术后达到教科书结局的可能性较低,需加强围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liver surgeons need to know the expected outcomes of laparoscopic liver resection (LLR) in obese patients. OBJECTIVE: The purpose of the present study is to assess morbidity, mortality and textbook outcomes (TO) after LLR in obese patients. METHODS: This is a French multicenter study of patients undergoing LLR between 1996 and 2018. Obesity was defined by a BMI at or above 30 kg/m 2 . Short-term outcomes and TO were compared between obese (ob) and nonobese (non-ob) patients. Factors associated with severe morbidity and TO were investigated. RESULTS: Of 3,154 patients included, 616 (19.5%) were obese. Ob-group patients had significantly higher American Society of Anesthesiologists (ASA) score and higher incidence of metabolic syndrome and chronic liver disease and were less likely to undergo major hepatectomy. Mortality rates were similar between ob and non-ob groups (0.8 vs 1.1%; p = 0.66). Overall morbidity and hospital stay were significantly increased in the ob group compared with the non-ob group (39.4 vs 34.7%, p = 0.03; and 9.5 vs 8.6 days, p = 0.02), whereas severe 90-day morbidity (at or above Clavien-Dindo grade III) was similar between groups (8% in both groups; p = 0.90). TO rate was significantly lower for the ob group than the non-ob group (58.3 vs 63.7%; p = 0.01). In multivariate analysis, obesity did not emerge as a risk factor for severe 90-day morbidity but was associated with a lower TO rate after LLR (odds ratio = 0.8, 95% CI 0.7-1.0; p = 0.03). CONCLUSIONS: LLR in obese patients is safe and effective with acceptable mortality and morbidity. Obesity had no impact on severe morbidity but was a factor for failing to achieve TO after LLR.
引用
- Genser L, Lim C, Barbier L, et al. Assessment of Factors Associated with Morbidity and Textbook Outcomes of Laparoscopic Liver Resection in Obese Patients: A French Nationwide Study. J Am Coll Surg. 2022. PMID: 35675176. doi:10.1097/XCS.0000000000000221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。